A circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan – 2020 to 2021

Abstract Background In this study, we describe the epidemiological profile of an outbreak of the circulating Vaccine Derived Polio Virus type 2 in South Sudan from 2020 to 2021. Method We conducted a retrospective descriptive epidemiological study using data from the national polio/AFP surveillance...

Full description

Bibliographic Details
Main Authors: Ayesheshem Ademe Tegegne, Atem Nathan Anyuon, George Awzenio Legge, Melisachew Adane Ferede, Zingbondo Isaac, Kirbak Anthony Laku, Sibhatu Biadgilign, Ochan Taban David Kilo, Fabian Ndenzako, Ndoutabe Modjirom, Olushayo Oluseun Olu, Sylvester Maleghemi
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-023-08758-z
_version_ 1827635466872029184
author Ayesheshem Ademe Tegegne
Atem Nathan Anyuon
George Awzenio Legge
Melisachew Adane Ferede
Zingbondo Isaac
Kirbak Anthony Laku
Sibhatu Biadgilign
Ochan Taban David Kilo
Fabian Ndenzako
Ndoutabe Modjirom
Olushayo Oluseun Olu
Sylvester Maleghemi
author_facet Ayesheshem Ademe Tegegne
Atem Nathan Anyuon
George Awzenio Legge
Melisachew Adane Ferede
Zingbondo Isaac
Kirbak Anthony Laku
Sibhatu Biadgilign
Ochan Taban David Kilo
Fabian Ndenzako
Ndoutabe Modjirom
Olushayo Oluseun Olu
Sylvester Maleghemi
author_sort Ayesheshem Ademe Tegegne
collection DOAJ
description Abstract Background In this study, we describe the epidemiological profile of an outbreak of the circulating Vaccine Derived Polio Virus type 2 in South Sudan from 2020 to 2021. Method We conducted a retrospective descriptive epidemiological study using data from the national polio/AFP surveillance database, the outbreak investigation reports, and the vaccination coverage survey databases stored at the national level. Results Between September 2020 and April 2021, 59 cases of the circulating virus were confirmed in the country, with 50 cases in 2020 and 9 cases in 2021. More cases were males (56%) under five (93%). The median age of the cases was 23.4 ± 11.9 months, ranging from 1 to 84 months. All states, with 28 out of the 80 counties, reported at least one case. Most of the cases (44, 75%) were reported from five states, namely Warrap (31%), Western Bahr el Ghazal (12%), Unity (12%), Central Equatoria (10%), and Jonglei (10%). Four counties accounted for 45.8% of the cases; these are Gogrial West with 12 (20%), Jur River with 5 (8.5%), Tonj North with 5 (8.5%), and Juba with 5 (8.5%) cases. The immunization history of the confirmed cases indicated that 14 (24%) of the affected children had never received any doses of oral polio or injectable vaccines either from routine or during supplemental immunization before the onset of paralysis, 17 (28.8%) had received 1 to 2 doses, while 28 (47.5%) had received 3 or more doses (Fig. 4). Two immunization campaigns and a mop-up were conducted with monovalent Oral Polio Vaccine type 2 in response to the outbreak, with administrative coverage of 91.1%, 99.1%, and 97% for the first, second, and mop-up rounds, respectively. Conclusion The emergence of the circulating vaccine-derived poliovirus outbreak in South Sudan was due to low population immunity, highlighting the need to improve the country’s routine and polio immunization campaign coverage.
first_indexed 2024-03-09T15:27:05Z
format Article
id doaj.art-3e0311ca507f417aad5bd46b56893761
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-03-09T15:27:05Z
publishDate 2023-11-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-3e0311ca507f417aad5bd46b568937612023-11-26T12:26:55ZengBMCBMC Infectious Diseases1471-23342023-11-0123111610.1186/s12879-023-08758-zA circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan – 2020 to 2021Ayesheshem Ademe Tegegne0Atem Nathan Anyuon1George Awzenio Legge2Melisachew Adane Ferede3Zingbondo Isaac4Kirbak Anthony Laku5Sibhatu Biadgilign6Ochan Taban David Kilo7Fabian Ndenzako8Ndoutabe Modjirom9Olushayo Oluseun Olu10Sylvester Maleghemi11World Health Organization Country OfficeMinistry of HealthMinistry of HealthWorld Health Organization Country OfficeMinistry of HealthWorld Health Organization Country OfficeWorld Health Organization Country OfficeWorld Health Organization Country OfficeWorld Health Organization Country OfficeWorld Health Organization Regional Office for AfricaWorld Health Organization Country OfficeWorld Health Organization Country OfficeAbstract Background In this study, we describe the epidemiological profile of an outbreak of the circulating Vaccine Derived Polio Virus type 2 in South Sudan from 2020 to 2021. Method We conducted a retrospective descriptive epidemiological study using data from the national polio/AFP surveillance database, the outbreak investigation reports, and the vaccination coverage survey databases stored at the national level. Results Between September 2020 and April 2021, 59 cases of the circulating virus were confirmed in the country, with 50 cases in 2020 and 9 cases in 2021. More cases were males (56%) under five (93%). The median age of the cases was 23.4 ± 11.9 months, ranging from 1 to 84 months. All states, with 28 out of the 80 counties, reported at least one case. Most of the cases (44, 75%) were reported from five states, namely Warrap (31%), Western Bahr el Ghazal (12%), Unity (12%), Central Equatoria (10%), and Jonglei (10%). Four counties accounted for 45.8% of the cases; these are Gogrial West with 12 (20%), Jur River with 5 (8.5%), Tonj North with 5 (8.5%), and Juba with 5 (8.5%) cases. The immunization history of the confirmed cases indicated that 14 (24%) of the affected children had never received any doses of oral polio or injectable vaccines either from routine or during supplemental immunization before the onset of paralysis, 17 (28.8%) had received 1 to 2 doses, while 28 (47.5%) had received 3 or more doses (Fig. 4). Two immunization campaigns and a mop-up were conducted with monovalent Oral Polio Vaccine type 2 in response to the outbreak, with administrative coverage of 91.1%, 99.1%, and 97% for the first, second, and mop-up rounds, respectively. Conclusion The emergence of the circulating vaccine-derived poliovirus outbreak in South Sudan was due to low population immunity, highlighting the need to improve the country’s routine and polio immunization campaign coverage.https://doi.org/10.1186/s12879-023-08758-zCirculating Vaccine Derived Polio Virus type 2cVDPV2 outbreakDescriptive epidemiologyOutbreak responseChronic humanitarianAnd conflict settings
spellingShingle Ayesheshem Ademe Tegegne
Atem Nathan Anyuon
George Awzenio Legge
Melisachew Adane Ferede
Zingbondo Isaac
Kirbak Anthony Laku
Sibhatu Biadgilign
Ochan Taban David Kilo
Fabian Ndenzako
Ndoutabe Modjirom
Olushayo Oluseun Olu
Sylvester Maleghemi
A circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan – 2020 to 2021
BMC Infectious Diseases
Circulating Vaccine Derived Polio Virus type 2
cVDPV2 outbreak
Descriptive epidemiology
Outbreak response
Chronic humanitarian
And conflict settings
title A circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan – 2020 to 2021
title_full A circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan – 2020 to 2021
title_fullStr A circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan – 2020 to 2021
title_full_unstemmed A circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan – 2020 to 2021
title_short A circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan – 2020 to 2021
title_sort circulating vaccine derived poliovirus type 2 outbreak in a chronic conflict setting a descriptive epidemiological study in south sudan 2020 to 2021
topic Circulating Vaccine Derived Polio Virus type 2
cVDPV2 outbreak
Descriptive epidemiology
Outbreak response
Chronic humanitarian
And conflict settings
url https://doi.org/10.1186/s12879-023-08758-z
work_keys_str_mv AT ayesheshemademetegegne acirculatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT atemnathananyuon acirculatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT georgeawzeniolegge acirculatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT melisachewadaneferede acirculatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT zingbondoisaac acirculatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT kirbakanthonylaku acirculatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT sibhatubiadgilign acirculatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT ochantabandavidkilo acirculatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT fabianndenzako acirculatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT ndoutabemodjirom acirculatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT olushayooluseunolu acirculatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT sylvestermaleghemi acirculatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT ayesheshemademetegegne circulatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT atemnathananyuon circulatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT georgeawzeniolegge circulatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT melisachewadaneferede circulatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT zingbondoisaac circulatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT kirbakanthonylaku circulatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT sibhatubiadgilign circulatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT ochantabandavidkilo circulatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT fabianndenzako circulatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT ndoutabemodjirom circulatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT olushayooluseunolu circulatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021
AT sylvestermaleghemi circulatingvaccinederivedpoliovirustype2outbreakinachronicconflictsettingadescriptiveepidemiologicalstudyinsouthsudan2020to2021